期刊文献+

心血管疾病患者二级预防药物治疗依从性对预后的影响 被引量:4

Effect of Compliance With Two Levels of Preventive Medication on Prognosis in Patients With Cardiovascular Disease
在线阅读 下载PDF
导出
摘要 目的分析对心血管疾病患者实施二级预防治疗对预后的影响。方法收集我院收治的240例心血管疾病患者作为研究对象,坚持规范二级预防用药120例,设置为观察组。不坚持规范用药依从性差的120例,设置为对照组。结果两组均有一定治疗效果,但观察组患者的治疗有效率高于对照组,同时观察组的并发症发生率低于对照组,差异均有统计学意义(P<0.05)。结论在对心血管疾病患者实施临床治疗时,坚持规范二级预防用药治疗的患者能够取得更好的治疗效果,预后更佳。 Objective To analyze the implementation of the two grade prevention of cardiovascular disease therapy on the prognosis of patients with cardiovascular disease.Methods 240 cases were collected in our hospital as the research object,adhere to the norms of the two grade prevention medication in 120 cases,as the observation group.120 cases do not adhere to the norms of poor compliance,as the control group.Results The two groups had a certain therapeutic effect,but the effective treatment of the observation group was significantly higher than that of control group,and the incidence rate of complication in observation group was significantly lower than the control group,all the differences were statistically significant(P〈0.05).Conclusion The implementation of the clinical treatment of patients with cardiovascular disease,adhere to the norms of two grade prevention treatment of patients to achieve better therapeutic effect,the prognosis is better.
作者 王熙明 WANG Ximing(Internal Medicine-cardiovascular Department, Zhang, ye People's Hospital, Zhangye Gansu 734000, Chin)
出处 《中国卫生标准管理》 2017年第4期76-77,共2页 China Health Standard Management
关键词 心血管疾病患者 二级预防药物治疗 依从性 预后的影响 cardiovascular disease patients two level preventive medicine compliance prognosis
  • 相关文献

参考文献8

二级参考文献132

  • 1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:223
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5249
  • 3Porto I, Van Gaal W, Banning A. Impact of the elevation of biochemical markers of myocardial damage on long term mortality after percutaneous coronary intervention: results of theCK MBand PCI study[J]. Eur Heart J, 2005,26(20): 2206-2207.
  • 4Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J]. J Am Coll Cardiol, 2009,54 (23) : 2157-2163.
  • 5Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early pereutaneous coronary intervention: results of the ARMYDA ACS randomized trial [J]. J Am Coll Cardiol, 2007,49(12) :1272- 1278.
  • 6Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention : results of the ARMYDA RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J]. J AmCollCardiol, 2009,54(6):558 -565.
  • 7Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives[J]. J Am Coll Cardiol, 2007,49(14) :1505 -1516.
  • 8Marian AJ. Cytochrome p-450 polymorphisms and response to clopidogrel[J]. Curr Atheroscler Rep, 2009,11(3):157-160.
  • 9Neubauer H, Gtinesdogan B, Hanefeld C, et al. Lipophilic statins interfere with the inhibitory effects of elopidogrel on platelet function-a flow cytometry study[J]. Eur Heart J, 2003,24(19) : 1744-1749.
  • 10Brophy JM, Babapulle MN, Costa V, et al. A pharmacoe pidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention[J]. Am Heart J, 2006,152(2) :263 -269.

共引文献66

同被引文献31

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部